Beyond Ozempic: The Future of Obesity Medicine with Dr. Mike Albert
Beyond Ozempic the future of obesity medicine with Dr. Mike Albert
The field of obesity medicine is constantly evolving, and keeping up with its progress can be challenging. That's why Dr. Mike Albert, a board-certified specialist in internal and obesity medicine and co-founder of Accomplish Health, has been invited to join the discussion. Accomplish Health is a telehealth practice focused on providing obesity care. In his off hours, Dr. Albert educates over 300,000 followers across social media about obesity.
In this episode, Dr. Albert shares the latest advancements, challenges, and future directions in obesity care. He offers insights into the impact of GLP-1 medications and hormone-based therapies, highlighting the shift in how obesity is perceived and treated. The conversation explores how the focus has moved from simple weight loss to addressing obesity as a complex chronic disease with metabolic implications.
Obesity Care: What’s Changing and Why It Matters
Obesity medicine has come a long way recently, evolving from a niche specialty into something much more widely recognized. A big reason for this is the rise of GLP-1 medications, which have completely changed the game with newer and more effective options. While some expected these changes, the speed and scale caught a lot of people off guard.
As more people start to see obesity as a chronic disease, it’s helped reduce stigma and empower patients. It’s also led to more doctors getting certified in obesity medicine and prescribing these treatments, showing a shift toward a more compassionate, patient-focused approach. But with this fast growth, some challenges have popped up. Big companies are jumping in, and sometimes it feels like making money is more important than quality care, which raises concerns about keeping the field’s integrity intact.
A lot of specialists got into obesity medicine because they genuinely want to help people who’ve been overlooked for too long. It’s tough for them to see the commercialization of care, where some companies offer quick fixes or low-quality services that might mislead vulnerable patients. The real challenge now is figuring out who’s providing well-rounded, thoughtful care—covering the biological, psychological, and social aspects—and who’s just pushing weight loss products, falling back on the same old diet-industry tactics.
Good obesity care should focus on building a strong doctor-patient relationship and taking a well-rounded approach. It’s not just about the meds; it’s about combining them with nutrition advice, exercise, and behavioral support. This way, treatment digs deeper than just prescribing pills and tackles the real issues affecting people’s weight and health. The goal now is to expand access to care without losing the standards that build trust and lead to real results.
The Real Deal on Obesity Treatment
The conversation about obesity treatment really shines a light on some big gaps in care, especially as the focus shifts more toward medications. One major concern is the rush to prescribe meds without creating a real connection between the patient and their provider.
Obesity isn’t just a passing issue; it’s a chronic condition that many people will deal with over the long haul. Signing up online for a prescription doesn’t cut it when it comes to the kind of ongoing support needed for success. Building a solid therapeutic relationship is crucial—it helps both the patient and the provider understand the journey ahead.
Then there are those telehealth pharmacies and prescription-as-a-service models. They might seem convenient, but they often just hand out meds and send patients on their way, which doesn’t help when it comes to real care. This approach is especially problematic for a condition like obesity, which has faced its fair share of stigma and inadequate treatment.
When you compare obesity care to other serious health conditions, it’s pretty eye-opening. Take cancer, for instance. Patients get a whole team of healthcare pros working together to support them through treatment. With obesity, it often feels like a quick, transactional encounter—no real thought put into it.
While medications like GLP-1s have definitely changed the game for obesity treatment, they’re just one piece of the puzzle. The truth is, obesity is complex, and it can stem from all sorts of factors—genetic, hormonal, psychological, and behavioral. That’s why effective management can’t be a one-size-fits-all deal; it requires a commitment to understanding and tackling the unique challenges each patient faces.
Hormone-Based Therapies
The future of obesity medicine looks promising, thanks to new therapies like GLP-1 medications and other hormone-based treatments. These options, including Wegovy and Zepbound, use hormones from the gastrointestinal tract to help regulate appetite and energy. What’s interesting is how these medications are more potent than naturally occurring hormones — all thanks to advances in biotechnology.
The latest GLP-1 drugs don’t just aid in weight loss—they also impact immune health, inflammation, and heart health. Dual-agonist therapies like Zepbound (tirzepatide) activate two receptors at once, offering even more health benefits. Other combinations, such as GLP-1 with glucagon (which plays a role in fat metabolism), could also help with conditions like liver disease and lipid disorders — those promising studies are still ongoing.
Researchers are also looking into cannabinoid (yes, like marijuana) receptor modulation, aiming to reverse leptin resistance, a big factor in obesity. This could lead to new treatments for metabolic issues like metabolic syndrome.
Overall, obesity medicine is moving beyond traditional methods, with therapies that offer better weight management and health outcomes, including improvements for conditions like fatty liver and sleep apnea. The hope is that these developments will bring more comprehensive and effective care to those dealing with obesity.
Rethinking Obesity: A Shift Toward Metabolic Health
Obesity medicine is moving beyond just focusing on weight to a broader view of metabolic health. The goal now is to treat obesity as a complex metabolic issue rather than just a weight problem. New therapies like GLP-1 receptor agonists are helping us see the connections between different organ systems, showing the need for a more integrated approach.
In the past, medical fields were often separated, leading to fragmented care when conditions overlapped. Now, specialists like cardiologists and hepatologists are dealing with conditions outside their usual scope, recognizing that everything is connected, and that metabolic health is key to overall wellness.
GLP-1 therapies highlight this shift by directly targeting metabolic issues, leading to real improvements in conditions like diabetes and obesity hypoventilation syndrome, and reducing the risk of heart attacks and strokes. By understanding early signs like insulin resistance, doctors can take action earlier and have a bigger impact.
Primary care will likely continue moving in this direction, focusing more on managing chronic and metabolic diseases. As outpatient care evolves, doctors might specialize further in handling these complex issues, separating them from acute problems. This integrated approach will help provide better outcomes for people facing obesity and metabolic challenges.
A Shift Toward Specialized Management
As healthcare continues to evolve, the way we manage chronic and metabolic diseases is set to change. Picture this: specialists will focus on the long-term stuff, while another group tackles those urgent health issues. It’s like creating a two-lane road in healthcare, where each lane has its own traffic.
One big challenge on the horizon is the shortage of primary care doctors, which isn’t going away anytime soon. Right now, a lot of primary care visits revolve around minor issues that are pretty straightforward to treat. With healthcare costs rising and the need for providers to work at their highest capacity, it makes sense that mid-level providers and nurse practitioners will step up to handle the routine stuff. They’ll be the ones taking care of things like sinus infections and regular check-ups, using tech tools to make their jobs easier and more efficient.
For patients with more complex health issues, family medicine doctors or internists will be the go-to. And only when things get really serious will folks need to see specialists like endocrinologists or cardiologists, especially since those fields are also facing their own shortages.
This new approach to care is all about managing chronic diseases better while keeping patients out of the hospital when possible. By having a solid support system in primary care, we can make sure that only the trickiest cases need specialist attention. Ultimately, this shift should lead to smoother, more effective care for everyone involved.
The Future of Obesity Care
Bringing everything together can be a challenge, but one thing is clear: the future of obesity treatment is promising. As we move further toward recognizing obesity as a chronic disease, integrating care into the broader healthcare system becomes even more essential. This means treating it like any other chronic condition, with a focus on multidisciplinary care.
Take a cue from the oncology model, where surgical specialists, medical oncologists, nurse practitioners, and registered dietitians collaborate seamlessly. They work together to provide comprehensive and high-value care for cancer patients, tailoring treatments to individual needs. This kind of integrated approach is exactly what obesity care is aiming for.
While the timeline for this transformation is uncertain, it’s a direction we’re headed in. In 20 or 30 years, it won’t be surprising to look back and see obesity recognized and managed just like any other chronic illness, with teams of specialists working in tandem to support patients on their health journeys. The goal is clear: better, more effective care that addresses the complexities of obesity and improves overall health outcomes.
With ongoing changes in obesity care, the focus is shifting to a more holistic strategy that merges medication with comprehensive support. Be sure to catch this informative episode!
More from The Dr. Francavilla Show:
Subscribe to The Dr. Francavilla Show on
Apple Podcasts, Spotify, Amazon Music, iHeartRadio, Stitcher